NYSE - BOATS Real Time Price
USD
McKesson Corporation (MCK)
750.63
-29.17
(-3.74%)
At close: June 18 at 4:00:02 PM EDT
752.07
+1.44
(+0.19%)
Overnight: 12:57:21 AM EDT
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Trade MCK on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for MCK
Chart does not reflect overnight price.
- Previous Close
779.80 - Open
775.72 - Bid --
- Ask --
- Day's Range
747.40 - 778.01 - 52 Week Range
637.00 - 999.00 - Volume
2,438,636 - Avg. Volume
1,041,867 - Market Cap (intraday)
87.882B - Beta (5Y Monthly) 0.31
- PE Ratio (TTM)
19.57 - EPS (TTM)
38.36 - Earnings Date (est.) Aug 5, 2026
- Forward Dividend & Yield 3.28 (0.44%)
- Ex-Dividend Date Jun 1, 2026
- 1y Target Est
941.40
Recent News
View More
Performance Overview
Trailing total returns as of 6/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
MCK
8.31%
S&P 500 (^GSPC)
9.57%
1-Year Return
MCK
3.40%
S&P 500 (^GSPC)
25.41%
3-Year Return
MCK
87.34%
S&P 500 (^GSPC)
70.10%
5-Year Return
MCK
317.12%
S&P 500 (^GSPC)
80.02%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/18/2026
-
Market Cap
87.88B
-
Enterprise Value
92.52B
-
Trailing P/E
19.56
-
Forward P/E
16.95
-
PEG Ratio (5yr expected)
1.47
-
Price/Sales (ttm)
0.23
-
Price/Book (mrq)
--
-
Enterprise Value/Revenue
0.23
-
Enterprise Value/EBITDA
12.89
Financial Highlights
Profitability and Income Statement
-
Profit Margin
1.18%
-
Return on Assets (ttm)
4.99%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
403.43B
-
Net Income Avi to Common (ttm)
4.76B
-
Diluted EPS (ttm)
38.36
Balance Sheet and Cash Flow
-
Total Cash (mrq)
3.98B
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
5.66B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
Adding growth drivers
McKesson, which is headquartered in Irving, Texas, operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical (until spun-off).
RatingPrice Target -
The major indices are mixed at midday on Thursday with the Nasdaq
The major indices are mixed at midday on Thursday with the Nasdaq lower and the Dow higher. Wall Street has one eye on tomorrow when the all-important Jobs report comes out for May. Crude oil is at $92 per barrel. The yield on the 10-year note is at 4.47%.
-
McKesson Closes Fiscal 2026 on Decent Note; Revenue Slowdown Is a Concern but Margin Looks Strong
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
RatingPrice Target -
McKesson Earnings: Revenue Slowdown Is a Concern, but Momentum in Margin and EPS Remains Strong
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
RatingPrice Target
